Esperion Therapeutics Inc ESPR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:27 PM EDT
2.41quote price arrow down-0.18 (-6.95%)
Volume
4,587,547
52 week range
0.70 - 3.40
Loading...
  • Open2.60
  • Day High2.60
  • Day Low2.40
  • Prev Close2.59
  • 52 Week High3.40
  • 52 Week High Date04/08/24
  • 52 Week Low0.70
  • 52 Week Low Date10/12/23

Key Stats

  • Market Cap456.58M
  • Shares Out189.46M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-19.4

KEY STATS

  • Open2.60
  • Day High2.60
  • Day Low2.40
  • Prev Close2.59
  • 52 Week High3.40
  • 52 Week High Date04/08/24
  • 52 Week Low0.70
  • 52 Week Low Date10/12/23
  • Market Cap456.58M
  • Shares Out189.46M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-19.4

RATIOS/PROFITABILITY

  • EPS (TTM)-1.00
  • P/E (TTM)-2.40
  • Fwd P/E (NTM)-7.70
  • EBITDA (TTM)-34.606M
  • ROE (TTM)-260.79%
  • Revenue (TTM)229.74M
  • Gross Margin (TTM)81.85%
  • Net Margin (TTM)-37.65%
  • Debt To Equity (MRQ)-89.04%

EVENTS

  • Earnings Date07/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Esperion Therapeutics Inc

 

Profile

MORE
Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company's NEXLETOL and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults...
J. Martin Carroll
Independent Chairman of the Board
Sheldon Koenig
President, Chief Executive Officer, Director
Benjamin Halladay
Chief Financial Officer
Benjamin Looker Esq.
General Counsel
Address
601 21St Street, Suite 300
Vero Beach, FL
32960
United States

Top Peers

SYMBOLLASTCHG%CHG
TVTX
Travere Therapeutics Inc
6.32-0.37-5.53%
AMRN
Amarin Corporation PLC
0.8985-0.0139-1.5235%
VNDA
Vanda Pharmaceuticals Inc
5.63+0.05+0.99%
HROW
Harrow Inc
17.12+0.96+5.94%
CSTL
Castle Biosciences Inc
24.45+0.23+0.95%